16 June 2023 in JMIR Public Health and Surveillance
CGCanadian Critical Care Trials Group
Canadian Critical Care Trials Group
+10
Background: The accuracy of self-reported vaccination status is important to guide real-world vaccine effectiveness studies and policy making in jurisdictions where access to electronic vaccine registries is restricted. Objective: This study aimed to determine the accuracy of self-reported vaccination status and reliability of the self-reported number of doses, brand, and time of vaccine administration. Methods: This diagnostic accuracy study was completed by the Canadian COVID-19 Emergency Department Rapid Response Network. We enrolled consecutive patients presenting to 4 emergency departments (EDs) in Québec between March 24, 2020, and December 25, 2021. We included adult patients who were able to consent, could speak English or French, and had a proven COVID-19 infection. We compared the self-reported vaccination status of the patients with their vaccination status in the electronic Québec Vaccination Registry. Our primary outcome was the accuracy of the self-reported vaccination status (index test) ascertained during telephone follow-up compared with the Québec Vaccination Registry (reference standard). The accuracy was calculated by dividing all correctly self-reported vaccinated and unvaccinated participants by the sum of all correctly and incorrectly self-reported vaccinated and unvaccinated participants. We also reported interrater agreement with the reference standard as measured by unweighted Cohen κ for self-reported vaccination status at telephone follow-up and at the time of their index ED visit, number of vaccine doses, and brand. Results: During the study period, we included 1361 participants. At the time of the follow-up interview, 932 participants reported at least 1 dose of a COVID-19 vaccine. The accuracy of the self-reported vaccination status was 96% (95% CI 95%-97%). Cohen κ for self-reported vaccination status at phone follow-up was 0.91 (95% CI 0.89-0.93) and 0.85 (95% CI 0.77-0.92) at the time of their index ED visit. Cohen κ was 0.89 (95% CI 0.87-0.91) for the number of doses, 0.80 (95% CI 0.75-0.84) for the brand of the first dose, 0.76 (95% CI 0.70-0.83) for the brand of the second dose, and 0.59 (95% CI 0.34-0.83) for the brand of the third dose. Conclusions: We reported a high accuracy of self-reported vaccination status for adult patients without cognitive disorders who can express themselves in English or French. Researchers can use self-reported COVID-19 vaccination data on the number of doses received, vaccine brand name, and timing of vaccination to guide future research with patients who are capable of self-reporting their vaccination data. However, access to official electronic vaccine registries is still needed to determine the vaccination status in certain susceptible populations where self-reported vaccination data remain missing or impossible to obtain. Trial Registration: Clinicaltrials.gov NCT04702945; https://clinicaltrials.gov/ct2/show/NCT04702945
30 September 2024 in Nature Communications
NRNetwork Of Canadian Emergency Researchers
Network Of Canadian Emergency Researchers
+41
Symptoms of the Post-COVID-19 Condition are often non-specific making it a challenge to distinguish them from symptoms due to other medical conditions. In this study, we compare the proportion of emergency department patients who developed symptoms consistent with the World Health Organization’s Post-COVID-19 Condition clinical case definition between those who tested positive for Severe Acute Respiratory Syndrome Coronavirus-2 infection and time-matched patients who tested negative. Our results show that over one-third of emergency department patients with a proven acute infection meet Post-COVID-19 Condition criteria 3 months post-index visit. However, one in five test-negative patients who claim never having been infected also report symptoms consistent with Post-COVID-19 Condition highlighting the lack of specificity of the clinical case definition. Testing for SARS-CoV-2 during the acute phase of a suspected infection should continue until specific biomarkers of Post-COVID-19 Condition become available for diagnosis and treatment.
23 February 2026 in Journal of the American Pharmacists Association
Older adults living with neurocognitive disorders (NCD) face a higher risk of polypharmacy, exposure to potentially inappropriate medications and related adverse events. Pharmacists can help manage these issues and improve the appropriateness of pharmacotherapy. To evaluate the impact of pharmacists' interventions, as members of primary care interprofessional teams, on medication use and patient-reported outcome measures among older adults living with or under investigation for a neurocognitive disorder. The effect of a six-month follow-up by a primary care interprofessional team pharmacist on the number of medications, potentially inappropriate medications (PIMs) and anticholinergic burden for older adults living at home under evaluation for or living with a NCD was assessed through a controlled quasi-experimental study. Eligible older adults were 65 years or older and were enrolled between September 2021 and February 2025. The patient-reported outcomes were the evolution of participants' quality of life, treatment burden and satisfaction with care. The outcomes were evaluated using difference in differences (D-I-D) and their 95% confidence interval (95% CI). Pharmacist interventions significantly reduced the mean anticholinergic burden in the intervention arm (n=177) compared to the control arm (n=128) (D-I-D: -0.29; 95% CI: -0.56 - -0.11). A non-statistically significant trend toward a reduction was also observed for the mean number of PIMs (D-I-D: -0.11; [-0.22; 0.00]). The interventions also improved participants' satisfaction with care (6.97; [0.23; 13.72]). The mean number of medications used, as well as the burden of treatment and quality of life were stable after follow-up. Pharmacist-led interventions in interprofessional primary care settings contributed to the appropriateness of pharmacotherapy and satisfaction of older adults under evaluation for or living with a NCD after a six-month follow-up.
29 April 2025 in Canadian Journal of Emergency Medicine
9 January 2026 in medRxiv
NRNetwork Of Canadian Emergency Researchers
Network Of Canadian Emergency Researchers
+1
Objectives: To investigate the factors associated with the deterioration of post-COVID-19 condition (PCC) symptoms in patients who received a dose of SARS-CoV-2 vaccine ≥ 90 days after their infection. Method: Multicenter cohort study conducted in 33 emergency departments across Canada, including 476 patients who developed PCC according to the World Health Organization definition. Data were collected via telephone questionnaires. Statistical analyses, including logistic regression models, were performed to identify factors associated with symptom deterioration after vaccination. Results: Among participants, 28.8% reported a deterioration of their PCC symptoms after vaccination. Two factors were significantly associated with this deterioration: receiving the Moderna (mRNA-1273) vaccine (aOR = 1.80; 95% CI: 1.14-2.8) and a persistent cough three months after the initial infection (aOR = 1.81; 95% CI: 1.03-3.15). No association was found between symptom deterioration and sociodemographic characteristics such as age or sex. Conclusion: Post-infection vaccination may be associated with increased risk of PCC symptoms deterioration in some patients, particularly those vaccinated with Moderna (mRNA-1273) or presenting with a persistent cough. While the benefits of vaccination remain substantial, these findings call for further investigation into the underlying immunological mechanisms and possible adjustments to vaccination strategies for patients with PCC.
31 December 2024 in medRxiv
ATAnnie Toulouse-Fournier
FRFor The Network Of Canadian Emergency Researchers
For The Network Of Canadian Emergency Researchers
+14
Objectives: Geriatric Emergency Management (GEM) nurses aim to reduce adverse outcomes by addressing unique needs of older adults seen in emergency departments (EDs), but evidence to demonstrate their impact on ED care transitions is mixed. We evaluated the impact of implementing a GEM nurse model in a local ED on thirty-day revisits using propensity score matching to control for relevant patient characteristics. Methods: A case-control design was used to analyze older adult patients who were triaged to a stretcher at an ED in Lévis, Québec, from October 2018 to September 2019. We used propensity score matching to compare patients who received the GEM nurse intervention with control patients who did not receive the intervention. This intervention involved a targeted geriatric ED assessment including history, physical exam, chart review, communication with caregivers and home care services, and the creation of an intervention and care transition plan to support safe discharge from the ED. We followed both the EQUATOR network’s brief guidelines for reporting a propensity score analysis and the STROBE guideline. Results: Out of 21,024 patients visiting the ED over a one-year period, 7,952 were eligible for analysis, with pre-matching differences showing GEM patients were older and more frequent ED users. Propensity score matching resulted in 724 patients with no significant differences in baseline characteristics between groups. Using a Cox regression analysis, we found a non-significant 6% decrease in the risk of ED revisit within 30 days for the GEM group (HR = 0.94, p = .692). Conclusions: The GEM nursing intervention targeting better care transition plans personalized to the needs of each patient did not significantly impact thirty-day revisits to the ED. Further work is needed to determine the most effective specific components of such interventions to maximize future positive impact on the care transitions of older patients. Clinician’s capsule: What is known about the topic?: Geriatric emergency management (GEM) nurses heterogeneously contribute to reducing emergency department revisits among older adults but may improve the quality of care. What did this study ask?: How would the implementation of a Geriatric Emergency Management (GEM) nurse intervention in a local emergency department (ED) impact 30-day revisits among older adults? What did this study find?: Despite not reaching statistical significance, we observed a 6% reduction in revisit rates. Why does this study matter to clinicians?: We should refine and support GEM nurse practices, along with shifting outcome measures from service-level metrics to patient-centered metrics like quality of life and symptom burden.